Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Chlebowski

Showing results (61-70 of 379) with videos related to

Pageof 38
Sort By:
Cancer Research|February 1, 1984
Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight lossR T Chlebowski, D Heber, B Richardson, et al.
Clinical Breast Cancer|April 6, 2006
Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy useRowan T Chlebowski, Garnet L Anderson, Michelle Geller, et al.
Oncotarget|May 30, 2019
Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal womenKathy Pan, Juhua Luo, Aaron K Aragaki, et al.
Clinical Trials (London, England)|September 14, 2010
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trialRowan T Chlebowski, Rashmi Menon, Roslyn M Chaisanguanthum, et al.
Journal of the American Dietetic Association|April 1, 1995
Dietary intake and counseling, weight maintenance, and the course of HIV infectionR T Chlebowski, M Grosvenor, L Lillington, et al.
Cancer Treatment Reports|January 1, 1982
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell lineR T Chlebowski, J B Block, D Cundiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Current attitudes and practice of American Society of Clinical Oncology-member clinical oncologists regarding cancer prevention and controlR T Chlebowski, J Sayre, M Frank-Stromborg, et al.
Journal of the National Cancer Institute|November 8, 2015
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass IndexRowan T Chlebowski, Garnet L Anderson, Aaron K Aragaki, et al.
Breast Cancer Research and Treatment|January 20, 2019
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsXiaoqing Xu, Rowan T Chlebowski, Jiaxiao Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifeneR T Chlebowski, D E Collyar, M R Somerfield, et al.
Pageof 38

Showing results (61-70 of 379) with videos related to

Sort By:
Pageof 38
Cancer Research|February 1, 1984
Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight lossR T Chlebowski, D Heber, B Richardson, et al.
Clinical Breast Cancer|April 6, 2006
Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy useRowan T Chlebowski, Garnet L Anderson, Michelle Geller, et al.
Oncotarget|May 30, 2019
Weight loss, diet composition and breast cancer incidence and outcome in postmenopausal womenKathy Pan, Juhua Luo, Aaron K Aragaki, et al.
Clinical Trials (London, England)|September 14, 2010
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trialRowan T Chlebowski, Rashmi Menon, Roslyn M Chaisanguanthum, et al.
Journal of the American Dietetic Association|April 1, 1995
Dietary intake and counseling, weight maintenance, and the course of HIV infectionR T Chlebowski, M Grosvenor, L Lillington, et al.
Cancer Treatment Reports|January 1, 1982
Doxorubicin cytotoxicity enhanced by local anesthetics in a human melanoma cell lineR T Chlebowski, J B Block, D Cundiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Current attitudes and practice of American Society of Clinical Oncology-member clinical oncologists regarding cancer prevention and controlR T Chlebowski, J Sayre, M Frank-Stromborg, et al.
Journal of the National Cancer Institute|November 8, 2015
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass IndexRowan T Chlebowski, Garnet L Anderson, Aaron K Aragaki, et al.
Breast Cancer Research and Treatment|January 20, 2019
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsXiaoqing Xu, Rowan T Chlebowski, Jiaxiao Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifeneR T Chlebowski, D E Collyar, M R Somerfield, et al.
Pageof 38